文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

应用知识:皮肤科医生移动应用程序的证据和监管。

APPlying knowledge: evidence for and regulation of mobile apps for dermatologists.

机构信息

Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA.

Department of Dermatology, Mount Sinai Health System, New York, New York; the Department of Dermatology, SUNY Downstate Health Sciences University, Brooklyn; and the Department of Dermatology, New York Harbor Healthcare System, Brooklyn, USA.

出版信息

Cutis. 2020 Aug;106(2):76-78. doi: 10.12788/cutis.0036.


DOI:10.12788/cutis.0036
PMID:32941561
Abstract

Although the complexity of health-related applications (apps) has evolved, they have not been adequately regulated or monitored for quality. We review the primary literature behind and regulation of apps that impact dermatologists, with a focus on the 3 most prevalent dermatology-related apps used by dermatology residents in the United States: VisualDx, UpToDate, and Mohs Surgery Appropriate Use Criteria. These apps are widely utilized but have not undergone approval by the 3 main government agencies responsible for regulating mobile medical apps: the US Food and Drug Administration (FDA), Federal Trade Commission, and Office for Civil Rights. Health-related apps that target providers can be a valuable tool, but given their potential impact on human lives, they should be well regulated and evidence based. It is important that apps designed to assist in health care delivery are appropriately monitored and that physicians are aware of the rigor of review of the apps that they choose to use in clinical practice.

摘要

尽管与健康相关的应用程序(apps)的复杂性已经发展,但它们的质量尚未得到充分监管或监测。我们回顾了影响皮肤科医生的 app 的主要文献和监管情况,重点介绍了美国皮肤科住院医师使用的 3 种最常见的皮肤科相关 app:VisualDx、UpToDate 和 Mohs 手术适用标准。这些应用程序被广泛使用,但没有经过负责监管移动医疗应用程序的 3 个主要政府机构的批准:美国食品和药物管理局(FDA)、联邦贸易委员会和公民权利办公室。针对医疗从业者的健康相关 app 可以成为一种有价值的工具,但考虑到它们对人类生活的潜在影响,它们应该受到良好的监管并基于证据。重要的是,设计用于辅助医疗保健的应用程序应受到适当的监控,并且医生应意识到他们在临床实践中选择使用的应用程序的审查严格程度。

相似文献

[1]
APPlying knowledge: evidence for and regulation of mobile apps for dermatologists.

Cutis. 2020-8

[2]
Expanded FDA regulation of health and wellness apps.

Bioethics. 2019-10-21

[3]
Current State of Dermatology Mobile Applications With Artificial Intelligence Features.

JAMA Dermatol. 2024-6-1

[4]
Growth of mobile applications in dermatology - 2017 update.

Dermatol Online J. 2018-2-15

[5]
FDA Regulation of Mobile Medical Apps.

JAMA. 2018-7-24

[6]
Mobile applications in dermatology.

JAMA Dermatol. 2013-11

[7]
Mobile App Usage Among Dermatology Residents in America.

Cutis. 2021-8

[8]
Usefulness of Smartphones in Dermatology: A US-Based Review.

Int J Environ Res Public Health. 2022-3-17

[9]
Mobile app rankings in dermatology.

Cutis. 2018-10

[10]
What is government's role in medical apps?

CMAJ. 2015-8-11

引用本文的文献

[1]
Efficacy of an Artificial Intelligence App (Aysa) in Dermatological Diagnosis: Cross-Sectional Analysis.

JMIR Dermatol. 2024-7-2

[2]
Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare.

Front Immunol. 2022

[3]
Digital skin imaging applications, part I: Assessment of image acquisition technique features.

Skin Res Technol. 2022-7

[4]
Usefulness of Smartphones in Dermatology: A US-Based Review.

Int J Environ Res Public Health. 2022-3-17

[5]
The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search.

J Med Internet Res. 2022-3-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索